EVOLUTION AT MERCK - INVENTING FOR LIFE

GROWING REVENUE DRIVEN BY DEMAND FOR INNOVATION IN THE FACE OF PRICING HEADWINDS ONCOLOGY VACCINES HOSPITAL / SPECIALTY¹ ANIMAL HEALTH MERCK INVENTING FOR LIFE Leading oncology portfolio with significant growth potential Durable growth with significant competitive advantages Broad portfolio delivering demand-driven growth Global leader delivering above-industry growth rates Expect strong revenue growth every year, including 2023 - the year of greatest impact of JANUVIA LOE 1 Includes specialty products in the pipeline that have not yet launched Rob Davis 10

View entire presentation